<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03853382</url>
  </required_header>
  <id_info>
    <org_study_id>257582</org_study_id>
    <nct_id>NCT03853382</nct_id>
  </id_info>
  <brief_title>Cognitive Analytic Therapy-informed Containment for Self-Harm (CATCH)</brief_title>
  <official_title>Cognitive Analytic Therapy-informed Containment for Self-Harm (CATCH): A Feasibility Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Manchester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-suicidal self-injury (NSSI) is when somebody engages in self-harm, such as cutting,
      without meaning to end his or her life. A large number of people engage in NSSI for lots of
      reasons, for example to cope with emotions. However, currently there are large waiting lists
      to access psychological therapy through the NHS. Therefore, it is important to research brief
      therapies so that individuals who engage in NSSI can receive treatment quicker. One
      potentially helpful therapy suggested is Cognitive Analytic Therapy (CAT), which focuses on
      patterns in relationships. NSSI can be understood as a way in which people relate to
      themselves, which suggests that CAT would fit well in terms of understanding and working with
      these difficulties.

      This study aims to evaluate a brief two-session CAT therapy for people who engage in NSSI.
      The project aims to evaluate the feasibility and acceptability of the therapy, using
      interviews and questionnaires. This means looking at whether participants stick with the
      therapy, and how they find taking part in the therapy.

      All participants will meet with a researcher for an initial session to complete baseline
      questionnaires about their current difficulties, thoughts and feelings. Participants will
      then be randomly allocated to a condition: either the therapy condition or the
      treatment-as-usual (TAU) condition. Participants in the therapy condition will receive two
      therapy sessions, whilst participants in the TAU condition will not receive any therapy
      sessions. All participants will attend a final session to complete more questionnaires.
      Participants will be asked to complete online surveys weekly. Some participants will be
      invited to take part in interviews about their experience of the therapy. All participants
      will receive a shopping voucher as compensation for their time. Using the data collected from
      this study, future work can be done to provide better treatment for people who engage in
      NSSI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability- attendance rates</measure>
    <time_frame>Five weeks</time_frame>
    <description>We will judge the intervention feasible based on whether &gt; 70% of those randomised to receive the intervention complete both sessions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety- adverse experiences</measure>
    <time_frame>Five weeks</time_frame>
    <description>Safety will be assessed via an Adverse Effects in Psychotherapy (AEP) self-report measure (Hutton, Byrne &amp; Morrison, 2017; unpublished). Items rated as greater than &quot;a little&quot; will be classified as notable adverse experiences. Adverse events occurring during the course of the trial (identified through discussion with the participant or clinical team) will also be monitored and recorded. These will include hospitalisation (related to mental health), medically serious self-harm (i.e. requiring medical intervention), and suicidal ideation where a plan and intent are present.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility - completion rate of assessments</measure>
    <time_frame>Five weeks</time_frame>
    <description>Feasibility will be based upon (i) &gt; 70% of participants attending the post-therapy follow-up point and (ii) a rate of missing data per outcome measure of &lt; 25% (this rate of missing data has been used to indicate high risk of bias within systematic reviews; Hutton et al., 2015).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Non-Suicidal Self-Injury</measure>
    <time_frame>Five weeks</time_frame>
    <description>Self-Injurious Thoughts and Behaviours Inventory Short-Form structured interview (SITBI-SF; Nock et al., 2007).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-Compassion Scale (SCS; Neff, 2003).</measure>
    <time_frame>Five weeks</time_frame>
    <description>The Self-Compassion Scale (SCS; Neff, 2003), assesses levels of self-compassion. The SCS includes 26 items rated on a scale of 1 (almost never) to 5 (almost always) as to how often participants engage in a range of thoughts or behaviours. The SCS includes six subscales including self-criticism (scores range from 5 to 25), self-kindness (scores range from 5 to 25), isolation (scores range from 4 to 20), common humanity (scores range from 4 to 20), over-identification (scores range from 4 to 20) and mindfulness (scores range from 4 to 20). Higher scores indicate greater self-compassion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>Five weeks</time_frame>
    <description>Patient Health Questionnaire (PHQ9; Kroenke et al., 2001).The PHQ9, used to assess depression, includes nine items and determines the extent to which participants have been bothered by difficulties over the last two weeks by rating on a scale of 0 (not at all) to 3 (nearly every day). Scores range from 0 to 27, with higher scores indicating greater symptom severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-concept instability</measure>
    <time_frame>Five weeks</time_frame>
    <description>The Personality Structure Questionnaire (PSQ; Pollock et al., 2001) will be used to assess self-concept stability. The PSQ includes 8 items rated on a five-point scale with opposite ends representing agreement with an unstable or stable sense of self. Scores range from 0 to 40 with greater scores indicating greater instability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-injury urges</measure>
    <time_frame>Five weeks</time_frame>
    <description>Alexian Brothers Urges to Self-injure scale (ABUSI; Washburn et al., 2010). The ABUSI asks participants to rate their urges to self-injure over the last week on frequency, strength, time thinking of self-injuring, and ability to resist. Score range from 0 to 30 with higher scores indicating more severe urges to self-injure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Self Harm</condition>
  <arm_group>
    <arm_group_label>Cognitive Analytic Informed Brief Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment As Usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive analytic informed brief therapy</intervention_name>
    <description>The brief CAT-informed therapy will take place over two sessions. Session one will last around 90 minutes. In session one, we will discuss with the participant their experience of self-harm and begin to support them to make sense of patterns in their self-harming behaviour. This will be done by thinking about the events that come before or follow self-harm, as well as thoughts and emotions associated with self-harm; it will also be done by thinking about ways that the participant relates to him/herself and other people. By the end of the first session, the researcher and the participant will have collaboratively developed a written diagram which shows patterns in the participant's self-harm.
Session two will involve revisiting the mapping of patterns. The researcher and participant will the collaboratively develop 'exits' or ways to break patterns and cycles of thinking, feeling and behaviour. Both sessions will have structured endings.</description>
    <arm_group_label>Cognitive Analytic Informed Brief Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Be aged over 16 years (parental consent is not needed; The British Psychological
             Society, 2008)

          2. Be comfortable with and have access to email and the internet for completing study
             measures

          3. Be currently under or receiving support form clinical/health service including NHS,
             3rd sector, or University health services

          4. Following DSM-V (American Psychiatric Association, 2013), have had five or more
             instances of NSSI in the past year:

             â€¢ NSSI methods are operationalised to include cutting, burning, biting, or scratching
             oneself, as well as head-banging or self-poisoning.

          5. Have an adequate English language ability to understand study materials

          6. Be deemed capable of providing informed consent by their clinical team.

        Exclusion Criteria:

          1. Be currently receiving any other psychological therapy (e.g. including but not limited
             to CBT and/or DBT), and will not have received psychological therapies in the last one
             month.

          2. Have previously received any CAT

          3. Have been diagnosed with Learning Disability or Autistic Spectrum Disorder as judged
             by clinical team - since the intervention has not been developed for this population

          4. Be currently judged at high risk of suicidal behaviour (although if participants were
             keen to be involved, they could be considered when their mental health has improved).

          5. Have been hospitalised as a result of self-harm in the past month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mersery Care NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Bruce</last_name>
      <phone>0151 471 2638</phone>
      <email>Karen.bruce@merseycare.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Peter Taylor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Greater Manchester Mental Health NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Leo</last_name>
      <phone>0161 271 0076</phone>
      <email>Sarah.Leo@gmmh.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Peter Taylor, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2019</study_first_posted>
  <last_update_submitted>September 24, 2019</last_update_submitted>
  <last_update_submitted_qc>September 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manchester</investigator_affiliation>
    <investigator_full_name>Peter Taylor</investigator_full_name>
    <investigator_title>clinical lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Self-Injurious Behavior</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Due to the small scale nature of the trial there is no plan to share Individual Patient Data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

